The drug, Wegovy, uses an active ingredient called Semaglutide which is part of a growing class of GLP-1 drugs that make ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount ...
Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes by a fifth, a “game-changing” new study has found. The anti-obesity injections could reduce the risk in obese people ...
Ozempic could dramatically reduce the risk of heart attacks and stroke, a new study indicates. The weight loss jab has become ...
A groundbreaking study has revealed that an anti-obesity jab containing semaglutide, a drug used to treat obesity, significantly reduces the risk of heart attacks and strokes, regardless of the ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an analysis of a study funded by a drug manufacturer. Researchers looked ...
Anti-obesity injections could lower the chances of serious heart disease in overweight individuals, regardless of their weight loss while on the medication, according to new research. A new study ...
A weight loss injection could reduce the risk of heart attacks and benefit the cardiovascular health of adults, according to a study on what could be the largest medical breakthrough since statins.
An anti-obesity drug could have additional health benefits including reducing the risk of heart attacks and strokes a new study has revealed. A five-year study was carried out by a team led ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...